// App-Quantinova.ai

: CNS Relapse Risk in Consecutive R-CHOP/R-Mini-CHOP-Treated Elderly DLBCL Is Low, with High Risk Particularly Apparent in Those with CNS IPI 5-6 and/or Renal/Adrenal Involvement

Researchers

Presenter

  • Toby A. Eyre

Principal Investigators

  • Nicolas Martinez-Calle

  • Amy A Kirkwood

  • Catherine Hildyard

  • Murali Kesavan

  • Joseph Butler

  • Carolyn Mercer

  • Faouzi Djebbari

  • Hannah Plaschkes

  • John Griffith

  • Stephen Booth

  • Andrew McMillan

  • Mark Bishton

  • Christopher P. Fox

  • Graham P. Collins

  • Chris Hatton

Medical Centers

  • Oxford University NHS Foundation Trust, Oxford, United Kingdom

  • Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom

  • Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom

  • Department of Haematology, Milton Keynes Hospital, Milton Keynes, United Kingdom

  • Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • Oxford University Medical School, Oxford, United Kingdom

  • Department of Haematology, Great Western Hospital, Swindon, United Kingdom

  • Department of Sexual Health, Royal Berkshire Hospital, Reading, United Kingdom

  • Nottingham City Hospital, Nottingham, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved